Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$75M |
| 2 |
Chevron
CVX
|
+$59.9M |
| 3 |
GE HealthCare
GEHC
|
+$57.5M |
| 4 |
Applovin
APP
|
+$54.7M |
| 5 |
OKLO
Oklo
OKLO
|
+$52.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xcel Energy
XEL
|
+$137M |
| 2 |
Meta Platforms (Facebook)
META
|
+$61.8M |
| 3 |
Becton Dickinson
BDX
|
+$59.9M |
| 4 |
CRWV
CoreWeave
CRWV
|
+$57.1M |
| 5 |
Apple
AAPL
|
+$50.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.73% |
| 2 | Financials | 9.81% |
| 3 | Utilities | 8.63% |
| 4 | Technology | 7.6% |
| 5 | Industrials | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Nuvation Bio
NUVB
$2.37B
| $180K | ﹤0.01% |
+92,250
| New | +$192K |
|
1327
ZIM Integrated Shipping Services
ZIM
$3.42B
| $179K | ﹤0.01% |
11,154
-12,794
| -53% | -$202K |
|
1328
Alpha Teknova
TKNO
$394M
| $177K | ﹤0.01% |
36,062
+20,431
| +131% | +$120K |
|
1329
First Commonwealth Financial
FCF
$2.12B
| $168K | ﹤0.01% |
10,361
-120,348
| -92% | -$1.86M |
|
1330
Green Plains
GPRE
$1.05B
| $168K | ﹤0.01% |
27,802
-105,742
| -79% | -$466K |
|
1331
Vertical Aerospace
EVTL
$135M
| $166K | ﹤0.01% |
+24,447
| New | +$115K |
|
1332
SoundHound AI
SOUN
$3.11B
| $158K | ﹤0.01% |
+14,750
| New | +$139K |
|
|
FYBR
1333
PUT
DELISTED
Frontier Communications
FYBR
| $157K | ﹤0.01% |
+4,300
| New | +$156K |
|
1334
Columbus McKinnon
CMCO
$518M
| $156K | ﹤0.01% |
10,239
-266,461
| -96% | -$4.07M |
|
|
LX
1335
LexinFintech Holdings
LX
$214M
| $155K | ﹤0.01% |
+21,464
| New | +$167K |
|
1336
Altimmune
ALT
$605M
| $152K | ﹤0.01% |
39,259
-1,668
| -4% | -$9.03K |
|
1337
Harmonic Inc
HLIT
$1.31B
| $150K | ﹤0.01% |
15,844
-7,429
| -32% | -$67.8K |
|
|
MAGN
1338
Magnera Corp
MAGN
$443M
| $149K | ﹤0.01% |
12,355
+2,261
| +22% | +$31.1K |
|
1339
Annexon
ANNX
$959M
| $148K | ﹤0.01% |
61,691
-121,596
| -66% | -$244K |
|
1340
Liberty Global Class C
LBTYK
$3.58B
| $147K | ﹤0.01% |
14,297
+4,998
| +54% | +$51.8K |
|
1341
Phathom Pharmaceuticals
PHAT
$701M
| $145K | ﹤0.01% |
15,146
-64,165
| -81% | -$355K |
|
1342
Wabash National
WNC
$491M
| $142K | ﹤0.01% |
+13,405
| New | +$129K |
|
1343
TETRA Technologies
TTI
$1B
| $141K | ﹤0.01% |
+41,870
| New | +$122K |
|
1344
United States Antimony
UAMY
$763M
| $135K | ﹤0.01% |
62,017
+39,885
| +180% | +$113K |
|
|
ALMS
1345
Alumis Inc
ALMS
$2.98B
| $133K | ﹤0.01% |
+44,222
| New | +$209K |
|
|
DHC
1346
Diversified Healthcare Trust
DHC
$1.94B
| $127K | ﹤0.01% |
+35,500
| New | +$102K |
|
|
FL
1347
CALL
DELISTED
Foot Locker
FL
| $120K | ﹤0.01% |
+4,900
| New | +$89K |
|
|
DFTX
1348
Definium Therapeutics
DFTX
$5.81B
| $116K | ﹤0.01% |
+17,877
| New | +$118K |
|
|
FLG
1349
Flagstar Bank National Association
FLG
$5.57B
| $115K | ﹤0.01% |
10,845
-691,213
| -98% | -$7.9M |
|
1350
Fluence Energy
FLNC
$1.55B
| $113K | ﹤0.01% |
+16,848
| New | +$80.3K |
|
Similar funds
Michael Gelband's Q2 2025 Portfolio in Review
As of Q2 2025, Michael Gelband held 2,093 positions worth $11.4B, up 13% from $10.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Michael Gelband deployed $528M of net new capital in Q2 2025, opening 704 new positions and adding to 330 existing holdings. Its largest new stake was Chevron: 424,949 shares worth $60.8M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Utilities.
On the sell side, the largest reduction was Xcel Energy, an estimated $137M trimmed.
- Michael Gelband's largest Q2 2025 buy was Chevron: 424,949 shares worth $60.8M.
- Michael Gelband added most to Paramount Global Class B in Q2 2025, an estimated $75M increase.
- Michael Gelband's biggest Q2 2025 reduction was Xcel Energy, cutting an estimated $137M.
- Michael Gelband fully exited Meta Platforms (Facebook) in Q2 2025, selling an estimated $61.8M.
- Michael Gelband's ten largest holdings make up 25% of its $11.4B portfolio in Q2 2025.
- Michael Gelband opened 704 new positions and closed 687 in Q2 2025.
- Michael Gelband's portfolio value rose 13% quarter-over-quarter to $11.4B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.